Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Ceralasertib | AZD6738 | ATR 激酶抑制剂 | 抗肿瘤 | TargetMol
AZD6738 | CAS#1352226-88-0 APExBIO 貨號B6007
JCI - ATR kinase inhibitor AZD6738 potentiates CD8+ T cell–dependent ...
Radiosensitization by the ATR Inhibitor AZD6738 through Generation of ...
Figure 1 from CYP-Mediated Sulfoximine Deimination of AZD6738 ...
Figure 6 from The ATR Inhibitor AZD6738 Synergizes with Gemcitabine In ...
ATR Inhibitor AZD6738 (Ceralasertib) Exerts Antitumor Activity as a ...
The ATR Inhibitor AZD6738 Synergizes with Gemcitabine In Vitro and In ...
AZD6738 induces DNA damage, apoptosis, and exhibits anti-tumor efficacy ...
Relationship between sensitivity to MK-8776 or AZD6738 and endogenous ...
AZD6738 monotherapy induces cell cycle arrest in sensitive cell lines ...
AZD6738 sensitizes NSCLC cell lines to cisplatin and synergizes ...
Frontiers | AZD6738 Inhibits fibrotic response of conjunctival ...
AZD6738 (Ceralasertib) - Chemietek
Single-Cell Transcriptional Analysis Reveals the Mechanism of AZD6738 ...
Anti‐tumor activity of the ATR inhibitor AZD6738 in HER2 positive ...
AZD6738 enhances 5-FU-induced apoptosis in HT29 cells. (A) HT29 cells ...
AZD6738 improves immune microenvironment in mice hepatocellular ...
The combination of AZD6738 and cisplatin causes dramatic cell death of ...
Anti-growth effect of AZD6738 in biliary tract cancer (BTC) cells. (A ...
AZD6738 – 美仑生物
ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy ...
Induction of apoptosis after treatment with gemcitabine and/or AZD6738 ...
AZD6738 abrogates the olaparib-induced DNA damage G2-M checkpoint a ...
The synergistic effect was observed with combinations of AZD6738 and ...
AZD6738 sensitizes ATM knockdown cells to cisplatin. A. Western blot ...
The orally active and bioavailable ATR kinase inhibitor AZD6738 ...
Effects of AZD6738 monotherapy or combined with CDC7 inhibitor in vivo ...
AZD6738 potentiates cisplatin efficacy in NSCLC xenografts, and the ...
CDC7 inhibitor synergies with AZD6738 or MK-8776 in HCC cells. a, b ...
CYP-Mediated Sulfoximine Deimination of AZD6738 - Drug Metabolism and ...
Targeting ATR Pathway in Solid Tumors: Evidence of Improving ...
ATR inhibitor-resistant cells express FOSB and activated MAPK pathway a ...
The potential impact of AZD6738 on DNA damage. (A) Comet assays were ...
(A) Clonogenic survival assay for AZD6738 in 231control and XRCC1_KO ...
The chemical structures of the ATR inhibitors VE-821, VX-970, AZD6738 ...
ATR inhibitor AZD6738 potentiates anti-proliferation of WEE1 inhibitor ...
ATR kinase inhibitor AZD6738 potentiates CD8+ T cell–dependent ...
Addition of AZD6738 potentiates radiation combined with anti-PD-L1 ...
ATR inhibition by AZD6738 exacerbates AZD1775-induced RS and abrogates ...
AZD6738 an ATR inhibitor in combination with belotecan demonstrate ...
AZD6738 in combination with FTD decreases Chk1 phosphorylation. HT29 ...
Combined olaparib and AZD6738 treatment results in earlier commitment ...
Promising new treatment for deadly pediatric tumors – Hale Plus Hearty
TOPBP1 as a potential predictive biomarker for enhanced combinatorial ...
Metronomic dosing of ovarian cancer cells with the ATR inhibitor ...
Bridging the gap between in vitro and in vivo: Dose and schedule ...
Scheme 3. Synthesis of AZD6738. | Download Scientific Diagram
Hypoxia‐Responsive Prodrug of ATR Inhibitor, AZD6738, Selectively ...
Ceralasertib (AZD6738) | ATM/ATR 抑制剂 | 现货供应 | 美国品牌 | 免费采购电话400-668-6834
Development and Scale-up of a Route to ATR Inhibitor AZD6738,Organic ...
Capivasertib (AZD5363) is an Orally Active and Potent Pan-AKT Kinase ...
Oncology Reports
Cytarabine induces cell cycle arrest and activates Chk1. U937 cells ...
A model for synthetic lethality in CLL cells with ATM or p53 deficiency ...
Synergism of AZD6738, an ATR Inhibitor, in Combination with Belotecan ...
The ATR inhibitor (AZD6738) and olaparib are synergistic in ...
AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality ...
Dual genome-wide CRISPR knockout and CRISPR activation screens identify ...
AZD6738, an ATR inhibitor, in combination with belotecan demonstrates ...
Phase II study of ceralasertib (AZD6738) in combination with durvalumab ...
Design, Synthesis, and Biological Evaluation of Potent and Selective ...
Effects of Combined Therapeutic Targeting of AXL and ATR on Pleural ...
The olaparib/AZD6738 combination is still selective for ATM deficiency ...
Discovery and Characterization of AZD6738, a Potent Inhibitor of Ataxia ...
AKT Serine/threonine Kinase Targeted Library | Kinase Targeted ...
Knockdown of RNF126 leads to decreased replication stress. A, C Western ...
Ceralasertib (AZD6738) | ATR Inhibitor | MedChemExpress
ATR inhibition radiosensitizes cells through augmented DNA damage and ...
(PDF) Hypoxia‐Responsive Prodrug of ATR Inhibitor, AZD6738, Selectively ...
